Viewing nowBIEL Simvastatin 20 mg Tablet
Simvastatin 20mg
Tablet · Prescription medication
Korea Chorus Co., Ltd.

MFDS item code 201804346 · Approved 2018.10.31 · Insurance code 647205310
Improvement of hyperlipidemia (including familial hypercholesterolemia in children), prevention of cardiovascular disease
This medication is particularly effective in adult patients with a history of cardiovascular diseases such as coronary heart disease, diabetes, peripheral vascular disease, and stroke. It reduces the risk of fatal coronary heart disease and lowers the risk of non-fatal myocardial infarction and stroke. It also helps reduce the risk of coronary and non-coronary vascular interventions. For patients with dyslipidemia, it is used as an adjunct to diet to lower total cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL cholesterol. It is also used in conjunction with diet to reduce total cholesterol and LDL cholesterol in pediatric patients with heterozygous familial hypercholesterolemia. Therefore, this medication is effectively used for the reduction of cardiovascular disease risk and improvement of dyslipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately based on the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is coadministered with fibrates (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, the initial dose should be 5 mg daily, with careful monitoring.
10 ~ 17 years of age: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication is used to lower blood cholesterol levels. There is a risk of muscle problems with this medication, particularly at high doses or when taken with certain drugs. If symptoms such as muscle pain, muscle weakness, or muscle tenderness occur, you must inform your doctor immediately. This medication is metabolized in the liver, so patients with liver function issues or liver disease should not take it. Women who are pregnant or may become pregnant, as well as those who are breastfeeding, should not take this medication. There are many drug interactions; concomitant use with certain antibiotics, antifungals, immunosuppressants, etc., may increase the risk of muscle damage. During the use of this medication, it is important to refrain from consuming alcohol and to regularly check liver function and muscle condition. Extra caution is needed for children, elderly individuals, patients with impaired kidney function, and those with hypothyroidism when using this medication. This medication may rarely cause liver function abnormalities, allergic reactions, neurological disorders, skin rashes, etc., so if any unusual symptoms occur, you must visit a hospital immediately. This medication cannot be given to patients with certain genetic lactose metabolism abnormalities, so if you have lactose intolerance, be sure to inform your healthcare provider. It is also advisable to avoid certain foods like grapefruit juice during treatment and to inform other doctors that you are taking this medication when prescribed other drugs. Dose adjustments and reviews of concomitant medications should be discussed with a specialist, and you should not stop or change the dosage on your own.
myopathy, rhabdomyolysis, abdominal pain, weakness, constipation, diarrhea, dyspepsia, bloating, nausea, headache, upper respiratory infection, edema, atrial fibrillation, gastritis, diabetes, myalgia, insomnia, dizziness, bronchitis, sinusitis, eczema, urinary tract infection, muscle cramps, arthralgia, dysgeusia, oculomotor dysfunction, facial paresis, tremor, sensory disturbance, peripheral neuropathy, peripheral nerve palsy, mental disorder, anxiety, sleep disorders, nightmares, depression, cognitive impairment, severe muscle weakness, ocular muscle weakness, hepatitis, liver function impairment, jaundice, pancreatitis, liver failure, cholestatic jaundice, hepatic steatosis, cirrhosis, fulminant hepatic necrosis, liver cancer, anorexia, vomiting, alopecia, pruritus, skin changes, fixed drug eruption resembling lichen planus, gynecomastia, decreased libido, sexual dysfunction, cataract progression, ocular muscle palsy, anemia, elevated aminotransferases, elevated ALP, elevated γ-GTP, elevated bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, interstitial lung disease, thrombocytopenia, lupus erythematosus-like syndrome, vasculitis, purpura, thrombocytopenic syndrome, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, eosinophilia, arthritis, urticaria, photosensitivity, fever, chills, flushing, malaise, dyspnea, toxic epidermal necrolysis, mucosal membrane syndrome, erythema multiforme, limb sensory numbness, tingling sensation, cold sensation, sensory disturbance
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is air-tight and kept at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its effectiveness for a longer time.
Brownish-yellow oval film-coated tablets
30 tablets, 300 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Korea Chorus Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.